66623-79-8

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-2-methoxythioanisole is used as an intermediate in the manufacturing of specialty chemicals for the pharmaceutical industry. It plays a crucial role in the synthesis of various pharmaceutical compounds, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
5-Bromo-2-methoxythioanisole is used as a reagent in the production of agrochemicals. Its applications in this industry include the synthesis of various agrochemical compounds, which are essential for crop protection and agricultural productivity.
Used in Organic Synthesis:
5-Bromo-2-methoxythioanisole is used as a building block in the development of new compounds for use in medicinal chemistry and drug discovery. Its unique chemical properties make it a valuable component in the synthesis of innovative and effective pharmaceuticals.
It is important to handle 5-Bromo-2-methoxythioanisole with caution, as it may pose hazards to human health and the environment if proper safety measures are not taken.

Upstream product

• 2388-73-0 1-methoxy-2-(methylsulfanyl)benzene 
• 624-92-0 Dimethyldisulphide 
• 21702-84-1 2,4-dibromoanisole 
• 23095-05-8 5-bromo-2-methoxybenzenesulfonyl chloride 
• 616-38-6 carbonic acid dimethyl ester 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 20828-73-3 methylsulfanylium 

Relevant academic research and scientific papers

Synthesis of Aryl Methyl Sulfides from Arysulfonyl Chlorides with Dimethyl Carbonate as the Solvent and C1 Source

A new procedure for the synthesis of aryl methyl sulfides from dimethyl carbonate (DMC) and arylsulfonyl chlorides has been achieved. In this strategy, DMC plays a dual role as both, C1 building block and green solvent. Arylsulfonyl chlorides served as the sulfur precursors, and a variety of aryl methyl sulfides were obtained in moderate to excellent yields with good functional group tolerance. Additionally, alkylsulfonyl chloride and dibenzyl carbonate are proven to be suitable substrates as well.

FUSED POLYCYCLIC HETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING COMPOUND AND ELECTRONIC DEVICE INCLUDING ORGANIC THIN FILM

A fused polycyclic heteroaromatic compound represented by Chemical Formula 1A or 1B that has a compact planar structure in which eight or more rings are fused together.

NEW SUBSTITUTED BIPHENYL ANALOGUES AS DUAL INHIBITORS OF AROMATASE AND SULFATASE

Provided are new biphenyl derivatives of formula (Ia). These compounds act as aromatase and sulfatase inhibitors. They are particularly useful for treating pathological conditions or diseases in which aromatase and sulfatase are involved. Moreover, provided are processes for the preparation of these compounds and pharmaceutical compositions containing said products and their use for the preparation of a medicament, in particular for the treatment of diseases characterized by aromatase and sulfatase activity such as hormone-dependent cancers.

Prostaglandin endoperoxide H synthase biosynthesis inhibitors

The present invention describes pyridazinone compounds of formula I which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important “housekeeping” enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectivity of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).

Electrophilic substitutions with the electrogenerated sulfenium cation R1-S+

The sulfenium cation R1-S+ electrogenerated by oxidation of organic disulfides, reacts with phenols, aromatic ethers and ketones bearing an hydrogen atom in α position, to give alkyl (aryl) sulfanyl compounds.